plantation [1] . Soon after their discovery, as early as 1960, the first side-effects of CP were reported by Coggins and co-workers [2] . These side-effects have been reported as transient irritative voiding symptoms, including urinary frequency, dysuria, urgency, suprapubic discomfort and strangury with microhematuria as well as life-threatening hemorrhagic cystitis. Bladder fibrosis, necrosis, contracture, and vesicoureteral reflux also have been reported [2] . Hemorrhage usually occurs during or immediately after treatment, whether with short-term high or long-term low dosages.
In 1981, Brock et al [3, 4] have documented that the urotoxicity of these cytostatics is not based on a direct alkylating activity on the urinary system but rather on the formation of 4-hydroxy metabolites, in particular, renal excretion of acrolein, which is formed from hepatic microsomal enzymatic hydroxylation. Following this discovery, experimental works have been made to elucidate how acrolein causes such a life-threatening side effect; hemorrhagic cystitis. A vast array of studies clearly showed that CP and IF-derived acrolein initiates a pathophysiological cascade beginning with oxidative [5] [6] [7] and nitrosative stress [8, 9] . Further studies indicate that a variety of cytokines [10-12], transcription factors and pro-inflammatory enzymes [9, 10, 13-15] have been involved acrolein-induced hemorrhagic cystitis. As a result, the overall mechanism appears as a well-established noninfectious inflammation [10, 16, 17 ].
In the current issue of the Journal of Experimental and Integrative Medicine, Ribeiro and co-workers [18], one of the leading groups in this area, extensively outlined how acrolein initiates the urological complications and all players involving the pathophysiological cascade of hemorrhagic cystitis. In this paper, acrolein-induced hemorrhagic cystitis has been perfectly explained and several cytokines and pro-inflammatory players involving the mechanism discussed in detailed [18] . We are confident that this paper will shed light on not only preventing of hemorrhagic cystitis occurrence but a vast array of other non-infectious conditions sharing with the similar pathophysiological mechanisms.
